Search - tctmd.com

Displaying 1 - 20 of 29

Sort: Relevancy | Date

News Daily News

AHA/ASA Release New Comprehensive Acute Ischemic Stroke Guideline

Todd Neale

January 29, 2026

News Daily News

Healthcare Expenses Increase After GLP-1 Prescription

L.A. McKeown

August 18, 2025

News Daily News

HOPE Supports IV Alteplase in Late Window After Acute Ischemic Stroke

Todd Neale

August 11, 2025

News Daily News

Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks

Michael O'Riordan

August 01, 2025

News Opinion CV Team Dispatch

January 2025 Dispatch for the CV Team

L.A. McKeown

January 24, 2025

News Daily News

AHA Statement Outlines Cardiac Contributions to Brain Health

L.A. McKeown

October 11, 2024

News Daily News

Only Small Minority of Eligible Patients Prescribed SGLT2 Inhibitors

Yael L. Maxwell

August 15, 2024

News Daily News

Experts Warn of Looming Private Equity Interest in Cardiology Care

Michael O'Riordan

January 15, 2024

News Daily News

First Drugs Chosen for Medicare Negotiations Hit Close to Home for Cardiologists

L.A. McKeown

August 31, 2023

News Daily News

New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization

Michael O'Riordan

July 20, 2023

News Daily News

COURAGE and ORBITA Had No Impact on Elective PCI Rates in UK

Michael O'Riordan

September 15, 2022

Dapagliflozin Boosts Health Status Across LVEF Range

Shelley Wood

May 23, 2022

News Daily News

Skipping Low-Value Cardiovascular Care Could Save Billions: AHA

Michael O'Riordan

March 01, 2022

News Features

COVID-19 Lockdown Inactivity May Spell Trouble for CVD Prevention

Michael O'Riordan

April 24, 2020

News Conference News ACC 2020

Diabetes May Boost Benefits of COMPASS Dual Antithrombotic Approach

Todd Neale

March 28, 2020

News Features

‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry

Michael O'Riordan

January 10, 2020

News Daily News

Vasospasm, Microvascular Dysfunction Tied to MACE in Nonobstructive CAD

Michael O'Riordan

November 05, 2019

News Conference News AHA 2018

Methotrexate, an Anti-inflammatory, Fails to Lower Risk of Cardiovascular Events: CIRT

Michael O'Riordan

November 10, 2018

News Daily News

Study Questions Incremental Benefit of Beta-Blockers After Acute MI

Michael O'Riordan

September 21, 2017

News Daily News

Hormone Therapy Doesn’t Impact Long-term All-Cause, CV, or Cancer Mortality: WHI Analysis

Caitlin E. Cox

September 14, 2017

Advertisement

AHA/ASA Release New Comprehensive Acute Ischemic Stroke Guideline

Healthcare Expenses Increase After GLP-1 Prescription

HOPE Supports IV Alteplase in Late Window After Acute Ischemic Stroke

Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks

January 2025 Dispatch for the CV Team

AHA Statement Outlines Cardiac Contributions to Brain Health

Only Small Minority of Eligible Patients Prescribed SGLT2 Inhibitors

Experts Warn of Looming Private Equity Interest in Cardiology Care

First Drugs Chosen for Medicare Negotiations Hit Close to Home for Cardiologists

New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization

COURAGE and ORBITA Had No Impact on Elective PCI Rates in UK

Dapagliflozin Boosts Health Status Across LVEF Range

Skipping Low-Value Cardiovascular Care Could Save Billions: AHA

COVID-19 Lockdown Inactivity May Spell Trouble for CVD Prevention

Diabetes May Boost Benefits of COMPASS Dual Antithrombotic Approach

‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry

Vasospasm, Microvascular Dysfunction Tied to MACE in Nonobstructive CAD

Methotrexate, an Anti-inflammatory, Fails to Lower Risk of Cardiovascular Events: CIRT

Study Questions Incremental Benefit of Beta-Blockers After Acute MI

Hormone Therapy Doesn’t Impact Long-term All-Cause, CV, or Cancer Mortality: WHI Analysis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content